[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335586-105":59,"doc-detail-335586-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","oncogenic-rtks-sensitize-cancer-cells-to-ferroptosis-via-c-myc-mediated-upregulation-of-acsl4","Oncogenic RTKs sensitize cancer cells to ferroptosis via c-Myc mediated upregulation of ACSL4","","Oncogenic RTK signaling through the RAS/RAF axis activates c-Myc and drives ferroptosis in cancer cells by increasing ACSL4 transcription. c-Myc directly binds the ACSL4 promoter, raising ACSL4 levels and sensitizing cells to ferroptosis caused by cysteine deprivation and RSL3 treatment. RTK pathway activity, including elevated EGFR or ErbB2, enhances vulnerability to ferroptosis in a mouse xenograft model, suggesting a ferroptosis-inducing intervention strategy for RTK-driven tumors.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/oncogenic-rtks-sensitize-cancer-cells-to-ferroptosis-via-c-myc-mediated-upregulation-of-acsl4/335586/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/oncogenic-rtks-sensitize-cancer-cells-to-ferroptosis-via-c-myc-mediated-upregulation-of-acsl4/335586.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-13","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How do oncogenic RTKs promote ferroptosis in cancer cells?","Question",{"text":112,"@type":113},"Oncogenic RTKs activate the RAS/RAF/c-Myc pathway, and c-Myc upregulates ACSL4, which sensitizes cancer cells to ferroptosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the role of c-Myc in regulating ACSL4 and ferroptosis?",{"text":117,"@type":113},"c-Myc binds the ACSL4 promoter region and increases ACSL4 expression, leading to enhanced sensitivity to ferroptosis-inducing conditions.",{"name":119,"@type":110,"acceptedAnswer":120},"Which treatments and model systems show increased ferroptosis sensitivity?",{"text":121,"@type":113},"ACSL4 upregulation sensitizes cells to cysteine deprivation and RSL3, and elevated EGFR or ErbB2 enhances ferroptosis vulnerability in a mouse xenograft model.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335586,1790460924,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nOncogenic RTKs sensitize cancer cells to ferroptosis via c-Myc mediated upregulation of ACSL4  \nNa Sun1, Jiawa Wang1, Jianhua Qin1, Shuang Ma1, Jing Luan1, Guoyuan Hou1, Wei Zhang 2 ✉ and Minghui Gao 1 ✉  \n© The Author(s) 2024  \n|  |  |  |\n| --- | --- | --- |\n|  | Alteration or abnormal activation of RTKs have been recurrently observed and recognized as an important driving factor in the progression of many human cancers. Ferroptosis, an iron-dependent form of regulated necrosis triggered by the accumulation of lethal lipid peroxides on cell membranes, has been implicated in various tumor types. Here we reported that oncogenic RTKs/RAS/ RAF/c-Myc axis promotes cancer cells to ferroptosis. Mechanistically, c-Myc binds to the promoter region of ACSL4 and promotes the expression of ACSL4, thereby sensitizes cells to ferroptosis. We further showed that RTKs/RAS/RAF promote ferroptosis by upregulating c-Myc mediated expression of ACSL4 in cancer cells. Notably, overexpression of RTKs enhances the vulnerability of melanoma to the ferroptosis inducer in mouse xenograft model. These ﬁndings may provide an attractive intervention strategy to |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| target cancers with oncogenic activation of RTKs via a ferroptosis-inducing approach. |  |  |\n|  | Cell Death and Disease (2024)15:861; [https://doi.org/10.1038/s41419-024-07254-9](https://doi.org/10.1038/s41419-024-07254-9) |  |\n|  |  |  |\n\nINTRODUCTION  \nFerroptosis, a form of cell death driven by iron-dependent lipid peroxidation, is regulated by multiple cellular metabolic processes, including redox homeostasis, iron handling, mitochondrial activity and the metabolism of amino acids, lipids and glucose [1] . Upon glutamate-cystine antiport system Xc − is inhibited and import of cystine is blocked, ferroptosis is triggered due to cysteine deprivation and glutathione depletion [2] . Glutathione peroxidase 4 (GPX4), the central negative regulator of ferroptosis [3], protects cells by catalyzing the reduction and thereby detoxiﬁes phospholipid hydroperoxides (PLOOHs) in mammalian cells. Certain cancer types are inherently susceptible to ferroptosis owing to their unique metabolic features. In epithelial cells, the intercellular interactions and intracellular NF2–YAP signaling play a crucial role in dictating ferroptotic death [4] . In non-small cell lung cancer cells (NSCLC), the LKB1-AMPK axis negatively regulates ferroptosis by inhibiting fatty acid synthesis [5] . As such, pharmacological induction of ferroptosis holds great potential for the treatment of certain cancers.  \nReceptor tyrosine kinases (RTKs) are a group of transmembrane cell-surface proteins that play an important role as signal transducers [6] . They regulate essential cellular processes like proliferation, apoptosis, differentiation and metabolism [7, 8] . Alteration of RTKs occurs across a broad spectrum of cancers, emphasizing their crucial role in cancer initiation, progression and their potential as therapeutic targets [9] . Dysregulation of RTKs/ RAS/RAF/c-Myc signaling leads to an assortment of human diseases, most notably, cancers [10–12] . Although the RTKs/RAS/ RAF/c-Myc signaling pathway plays a role in regulating ferroptosis [13–16], the detailed mechanism by which they regulate ferroptosis remains to be further investigated.  \nHere we show that oncogenic activation of RTKs/RAS/RAF signaling pathway promotes cancer cell ferroptosis via c-Myc mediated upregulation of ACSL4 . Moreover, we identiﬁed a new regulatory mechanism by which the proto-oncogenic transcription factor c-Myc promotes ferroptosis through upregulating the ferroptosis modulator ACSL4 . ACSL4 upregulation further confers sensitivity to ferroptosis induced by cysteine deprivation and RSL3 treatment. Finally, elevated EGFR or ErbB2 levels sensitize cancer cells to ferroptosis-inducing treatment in a mouse xeno","cbCaitsqIVnRqy3K","https://ap.wps.com/l/cbCaitsqIVnRqy3K","pdf",3374247,11,"English","# Introduction\n# Results\n## Oncogenic RTKs promote cancer cells ferroptosis","[{\"question\":\"How do oncogenic RTKs promote ferroptosis in cancer cells?\",\"answer\":\"Oncogenic RTKs activate the RAS/RAF/c-Myc pathway, and c-Myc upregulates ACSL4, which sensitizes cancer cells to ferroptosis.\"},{\"question\":\"What is the role of c-Myc in regulating ACSL4 and ferroptosis?\",\"answer\":\"c-Myc binds the ACSL4 promoter region and increases ACSL4 expression, leading to enhanced sensitivity to ferroptosis-inducing conditions.\"},{\"question\":\"Which treatments and model systems show increased ferroptosis sensitivity?\",\"answer\":\"ACSL4 upregulation sensitizes cells to cysteine deprivation and RSL3, and elevated EGFR or ErbB2 enhances ferroptosis vulnerability in a mouse xenograft model.\"}]","Oncogenic RTKs sensitize cancer cells to ferroptosis via c-Myc mediated upregulation of ACSL4 | PDF",1790011531,28]